Schedule 13G ownership disclosure

CYCLACEL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 23254L603

Event date: 2020-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-041790
Form type
SC 13G
Filer
ACORN BIOVENTURES, L.P.
CIK
CIK 1766853
Filed
Feb 12, 2021
Reporting period
Dec 18, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub